市場調査レポート

商品コード

1179530

肺機能検査装置市場：製品タイプ別、検査タイプ別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Pulmonary Function Testing Devices Market By Product, By Test Type, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年09月01日 | 発行: Allied Market Research

| ページ情報: 英文 341 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,840 604,915円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 6,090 959,357円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 10,500 1,654,065円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.53円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

肺機能検査は、肺が行う吸気と呼気の機能の有効性を判断し、測定することができる一連の検査です。

肺機能検査は、血液中への酸素の効率的な移動を判断する上で極めて重要な役割を果たし、息切れの原因を特定するとともに、喘息、気管支炎、肺気腫などの特定の種類の肺疾患の診断に役立ちます。

一般的な肺機能検査の種類には、スパイロメトリー（Spirometry）があります。スパイロメトリーでは、人がどれだけ空気を吸い込み、吐き出すことができるかを測定します。また、肺の中の空気をどれだけ速く空にできるかも測定します。この検査は、酸素が肺から血流にどれだけうまく移動しているかをチェックするために行われます。

市場の成長を促進する主な要因は、肺がんおよび肺関連疾患の有病率の上昇、老人人口の増加、および世界中で技術的に高度な医療機器の採用が進んでいることです。さらに、キー全体の肺疾患のための低侵襲性テストの需要の上昇は、さらに市場の成長を後押しする重要な要因です。例えば、世界保健機関によると、2020年には、慢性閉塞性肺疾患（COPD）が世界の死因の第3位となりました。約390万人がCOPDが原因で死亡したと推定されています。さらに、老年人口の増加や慢性肺疾患の有病率の上昇により、世界中で疾患診断のための肺機能検査装置の需要が増加しており、市場の成長をさらに後押ししています。

さらに、肺機能検査装置の研究開発活動の増加や医療費の増加が、市場の成長をさらに後押ししています。しかし、医療機器のコスト高や肺機能検査に対する認知度の低さが市場成長を阻害しています。逆に、新興国のヘルスケア市場は、予測期間中に市場で活動する主要なプレーヤーに有利な機会を提供することが期待されます。

概要
- 市場規模・予測
ポータブルPFTデバイス
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
- ポータブルPFTデバイス、肺機能検査装置市場：タイプ別
  - ハードウェアの市場規模・予測：地域別
  - ソフトウェア市場規模・予測：地域別
コンプリートPFTデバイス
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
- コンプリートPFTデバイス、肺機能検査装置市場：タイプ別
  - ハードウェアの市場規模・予測：地域別
  - ソフトウェア市場規模・予測：地域別

第5章肺機能検査装置市場：検査タイプ別

概要
- 市場規模・予測
スピロメトリー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ピークフローメーター
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
肺活量検査
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
ガス交換試験
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
最大自発換気量
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第6章肺機能検査装置市場：用途別

概要
- 市場規模・予測
慢性閉塞性肺疾患分野
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
喘息
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
慢性的な息切れ
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
肺抑制要因性疾患
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第7章肺機能検査装置市場：エンドユーザー別

概要
- 市場規模・予測
病院
- 主な市場動向、成長要因と機会
- 市場規模・予測：地域別
- 市場分析：国別
臨床検査室
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
診断用ラボラトリー
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第8章肺機能検査装置市場：地域別

概要
- 市場規模・予測
北米
- 主な動向と機会
- 北米市場規模・予測：製品別
  - 北米のポータブルPFTデバイス肺機能検査装置市場：タイプ別
  - 北米の完全型PFT装置肺機能検査装置市場：タイプ別
- 北米市場規模・予測：検査タイプ別
- 北米の市場規模・予測：アプリケーション別
- 北米市場の市場規模・予測：エンドユーザー別
- 北米市場の規模・予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州の市場規模・予測：製品別
  - 欧州のポータブルPFTデバイス肺機能検査装置市場：タイプ別
  - 欧州の完全型PFT装置肺機能検査装置市場：タイプ別
- 欧州市場規模・予測：検査タイプ別
- 欧州市場規模・予測：アプリケーション別
- 欧州市場規模・予測：エンドユーザー別
- 欧州市場規模・予測：国別
  - フランス
  - ドイツ
  - イタリア
  - 英国
  - スペイン
  - その他欧州
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：製品別
  - アジア太平洋地域のポータブルPFTデバイス肺機能検査装置市場：タイプ別
  - アジア太平洋地域の完全型PFT装置肺機能検査装置市場：タイプ別
- アジア太平洋地域の市場規模・予測：検査タイプ別
- アジア太平洋地域の市場規模・予測：アプリケーション別
- アジア太平洋地域の市場規模・予測：エンドユーザー別
- アジア太平洋地域の市場規模・予測：国別
  - 日本
  - 中国
  - インド
  - オーストラリア
  - 韓国
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：製品別
  - LAMEAの携帯型PFTデバイス肺機能検査装置市場：タイプ別
  - LAMEA Complete PFT Devices肺機能検査装置市場：タイプ別
- LAMEAの肺機能検査装置市場規模・予測：検査タイプ別
- LAMEAの市場規模・予測：アプリケーション別
- LAMEAの市場規模・予測：エンドユーザー別
- LAMEAの市場規模・予測：国別
  - ブラジル
  - サウジアラビア
  - 南アフリカ共和国
  - LAMEAの残りの地域

第9章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第10章企業プロファイル

SCHILLER
COSMED srl
NSPIRE HEALTH INC
MGC Diagnostics Corporation
ndd Medizintechnik AG
Morgan Scientific Inc.,
Ganshorn Medizin Electronic
Minato Holdings Inc
CHEST M.I., Inc
Medical Equipment Europe

図表

LIST OF TABLES

TABLE 1. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR PORTABLE PFT DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 3. PULMONARY FUNCTION TESTING DEVICES MARKET FOR PORTABLE PFT DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 6. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 7. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR COMPLETE PFT DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 8. PULMONARY FUNCTION TESTING DEVICES MARKET FOR COMPLETE PFT DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. GLOBAL COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 10. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HARDWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 11. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 12. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 13. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR SPIROMETRY, BY REGION, 2021-2031 ($MILLION)
TABLE 14. PULMONARY FUNCTION TESTING DEVICES MARKET FOR SPIROMETRY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR PEAK FLOW METER, BY REGION, 2021-2031 ($MILLION)
TABLE 16. PULMONARY FUNCTION TESTING DEVICES MARKET FOR PEAK FLOW METER, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR LUNG VOLUME TEST, BY REGION, 2021-2031 ($MILLION)
TABLE 18. PULMONARY FUNCTION TESTING DEVICES MARKET FOR LUNG VOLUME TEST, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR GAS EXCHANGE TESTING, BY REGION, 2021-2031 ($MILLION)
TABLE 20. PULMONARY FUNCTION TESTING DEVICES MARKET FOR GAS EXCHANGE TESTING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR MAXIMAL VOLUNTARY VENTILATION, BY REGION, 2021-2031 ($MILLION)
TABLE 22. PULMONARY FUNCTION TESTING DEVICES MARKET FOR MAXIMAL VOLUNTARY VENTILATION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 24. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 26. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2021-2031 ($MILLION)
TABLE 27. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR ASTHMA, BY REGION, 2021-2031 ($MILLION)
TABLE 29. PULMONARY FUNCTION TESTING DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CHRONIC SHORTNESS OF BREATH, BY REGION, 2021-2031 ($MILLION)
TABLE 31. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CHRONIC SHORTNESS OF BREATH, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR RESTRICTIVE LUNG DISEASE, BY REGION, 2021-2031 ($MILLION)
TABLE 33. PULMONARY FUNCTION TESTING DEVICES MARKET FOR RESTRICTIVE LUNG DISEASE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 34. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 35. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 36. GLOBAL PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 37. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR HOSPITAL, BY REGION, 2021-2031 ($MILLION)
TABLE 38. PULMONARY FUNCTION TESTING DEVICES MARKET FOR HOSPITAL, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR CLINICAL LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 40. PULMONARY FUNCTION TESTING DEVICES MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 41. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 42. PULMONARY FUNCTION TESTING DEVICES MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 43. PULMONARY FUNCTION TESTING DEVICES MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 44. PULMONARY FUNCTION TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 45. PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 46. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 47. NORTH AMERICA PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. NORTH AMERICA COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 49. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 50. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 51. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 52. NORTH AMERICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 53. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 54. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 55. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 56. U.S. PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 58. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 59. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. CANADA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 63. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 64. MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 65. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 66. EUROPE PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. EUROPE COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 68. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 69. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 70. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 71. EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 72. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 73. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 74. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 75. FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 78. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 82. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 83. ITALY PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 86. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 87. UK PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 90. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 91. SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 92. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 94. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 95. REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 96. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 97. ASIA-PACIFIC PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 98. ASIA-PACIFIC COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 99. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 100. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 101. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 102. ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 103. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 104. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 105. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 106. JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 107. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 108. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 109. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 110. CHINA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 111. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 112. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 113. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 114. INDIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 115. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 116. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 117. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 118. AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 119. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 120. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 121. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 122. SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 123. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 124. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 125. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 126. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 127. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 128. LAMEA PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 129. LAMEA COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 130. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 131. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 132. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 133. LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 134. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 135. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 136. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 137. BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 138. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 139. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 140. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 141. SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 142. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 143. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 144. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 145. SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 146. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 147. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE, 2021-2031 ($MILLION)
TABLE 148. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 149. REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 150.SCHILLER: COMPANY SNAPSHOT
TABLE 151.SCHILLER: OPERATING SEGMENTS
TABLE 152.SCHILLER: PRODUCT PORTFOLIO
TABLE 153.SCHILLER: NET SALES,
TABLE 154.SCHILLER: KEY STRATERGIES
TABLE 155.COSMED SRL: COMPANY SNAPSHOT
TABLE 156.COSMED SRL: OPERATING SEGMENTS
TABLE 157.COSMED SRL: PRODUCT PORTFOLIO
TABLE 158.COSMED SRL: NET SALES,
TABLE 159.COSMED SRL: KEY STRATERGIES
TABLE 160.NSPIRE HEALTH INC: COMPANY SNAPSHOT
TABLE 161.NSPIRE HEALTH INC: OPERATING SEGMENTS
TABLE 162.NSPIRE HEALTH INC: PRODUCT PORTFOLIO
TABLE 163.NSPIRE HEALTH INC: NET SALES,
TABLE 164.NSPIRE HEALTH INC: KEY STRATERGIES
TABLE 165.MGC DIAGNOSTICS CORPORATION: COMPANY SNAPSHOT
TABLE 166.MGC DIAGNOSTICS CORPORATION: OPERATING SEGMENTS
TABLE 167.MGC DIAGNOSTICS CORPORATION: PRODUCT PORTFOLIO
TABLE 168.MGC DIAGNOSTICS CORPORATION: NET SALES,
TABLE 169.MGC DIAGNOSTICS CORPORATION: KEY STRATERGIES
TABLE 170.NDD MEDIZINTECHNIK AG: COMPANY SNAPSHOT
TABLE 171.NDD MEDIZINTECHNIK AG: OPERATING SEGMENTS
TABLE 172.NDD MEDIZINTECHNIK AG: PRODUCT PORTFOLIO
TABLE 173.NDD MEDIZINTECHNIK AG: NET SALES,
TABLE 174.NDD MEDIZINTECHNIK AG: KEY STRATERGIES
TABLE 175.MORGAN SCIENTIFIC INC.,: COMPANY SNAPSHOT
TABLE 176.MORGAN SCIENTIFIC INC.,: OPERATING SEGMENTS
TABLE 177.MORGAN SCIENTIFIC INC.,: PRODUCT PORTFOLIO
TABLE 178.MORGAN SCIENTIFIC INC.,: NET SALES,
TABLE 179.MORGAN SCIENTIFIC INC.,: KEY STRATERGIES
TABLE 180.GANSHORN MEDIZIN ELECTRONIC: COMPANY SNAPSHOT
TABLE 181.GANSHORN MEDIZIN ELECTRONIC: OPERATING SEGMENTS
TABLE 182.GANSHORN MEDIZIN ELECTRONIC: PRODUCT PORTFOLIO
TABLE 183.GANSHORN MEDIZIN ELECTRONIC: NET SALES,
TABLE 184.GANSHORN MEDIZIN ELECTRONIC: KEY STRATERGIES
TABLE 185.MINATO HOLDINGS INC: COMPANY SNAPSHOT
TABLE 186.MINATO HOLDINGS INC: OPERATING SEGMENTS
TABLE 187.MINATO HOLDINGS INC: PRODUCT PORTFOLIO
TABLE 188.MINATO HOLDINGS INC: NET SALES,
TABLE 189.MINATO HOLDINGS INC: KEY STRATERGIES
TABLE 190.CHEST M.I., INC: COMPANY SNAPSHOT
TABLE 191.CHEST M.I., INC: OPERATING SEGMENTS
TABLE 192.CHEST M.I., INC: PRODUCT PORTFOLIO
TABLE 193.CHEST M.I., INC: NET SALES,
TABLE 194.CHEST M.I., INC: KEY STRATERGIES
TABLE 195.MEDICAL EQUIPMENT EUROPE: COMPANY SNAPSHOT
TABLE 196.MEDICAL EQUIPMENT EUROPE: OPERATING SEGMENTS
TABLE 197.MEDICAL EQUIPMENT EUROPE: PRODUCT PORTFOLIO
TABLE 198.MEDICAL EQUIPMENT EUROPE: NET SALES,
TABLE 199.MEDICAL EQUIPMENT EUROPE: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.PULMONARY FUNCTION TESTING DEVICES MARKET SEGMENTATION
FIGURE 2.PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031
FIGURE 3.PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.PULMONARY FUNCTION TESTING DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.PULMONARY FUNCTION TESTING DEVICES MARKET,BY PRODUCT,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF PORTABLE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF COMPLETE PFT DEVICES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 15.PULMONARY FUNCTION TESTING DEVICES MARKET,BY TEST TYPE,2021(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SPIROMETRY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PEAK FLOW METER PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF LUNG VOLUME TEST PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF GAS EXCHANGE TESTING PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MAXIMAL VOLUNTARY VENTILATION PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 22.PULMONARY FUNCTION TESTING DEVICES MARKET,BY APPLICATION,2021(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ASTHMA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF CHRONIC SHORTNESS OF BREATH PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF RESTRICTIVE LUNG DISEASE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 28.PULMONARY FUNCTION TESTING DEVICES MARKET,BY END USER,2021(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF HOSPITAL PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF CLINICAL LABORATORIES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 31.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC LABORATORIES PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 32.COMPARATIVE SHARE ANALYSIS OF OTHERS PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031(%)
FIGURE 33.PULMONARY FUNCTION TESTING DEVICES MARKET BY REGION,2021
FIGURE 34.U.S. PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 35.CANADA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 36.MEXICO PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 37.FRANCE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 38.GERMANY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 39.ITALY PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 40.UK PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 41.SPAIN PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 42.REST OF EUROPE PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 43.JAPAN PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 44.CHINA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 45.INDIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 46.AUSTRALIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 47.SOUTH KOREA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 48.REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 49.BRAZIL PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 50.SAUDI ARABIA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 51.SOUTH AFRICA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 52.REST OF LAMEA PULMONARY FUNCTION TESTING DEVICES MARKET,2021-2031($MILLION)
FIGURE 53. TOP WINNING STRATEGIES, BY YEAR
FIGURE 54. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 55. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 56.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 57.COMPETITIVE DASHBOARD
FIGURE 58.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 59.SCHILLER.: NET SALES ,($MILLION)
FIGURE 60.COSMED SRL.: NET SALES ,($MILLION)
FIGURE 61.NSPIRE HEALTH INC.: NET SALES ,($MILLION)
FIGURE 62.MGC DIAGNOSTICS CORPORATION.: NET SALES ,($MILLION)
FIGURE 63.NDD MEDIZINTECHNIK AG.: NET SALES ,($MILLION)
FIGURE 64.MORGAN SCIENTIFIC INC.,.: NET SALES ,($MILLION)
FIGURE 65.GANSHORN MEDIZIN ELECTRONIC.: NET SALES ,($MILLION)
FIGURE 66.MINATO HOLDINGS INC.: NET SALES ,($MILLION)
FIGURE 67.CHEST M.I., INC.: NET SALES ,($MILLION)
FIGURE 68.MEDICAL EQUIPMENT EUROPE.: NET SALES ,($MILLION)

Product Code: A03407

Pulmonary function testing is a series of tests that can determine as well as measure the efficacy of inhaling and exhaling functions performed by the lungs. It plays a pivotal role in determining the efficient transfer of oxygen into the blood and helps in diagnosing certain types of lung diseases such as asthma, bronchitis, and emphysema, along with determining the cause of shortness of breath.

Some of the common types of pulmonary function tests are spirometry. Spirometry measures how much air a person can breathe in and out. It also measures how fast a person can empty the air out of the lungs. This test is done to check how well the oxygen moves from the lungs into the bloodstream.

The key factors that drive the growth of the market are the rise in the prevalence of lung cancer and lung-related disorders; rise in the geriatric population; and the increase in adoption of technologically advanced medical devices across the world. In addition, rise in the demand for minimally invasive tests for lung diseases across the key is the key factor which further boosts the market growth. For instance, according to the World Health Organization, in 2020, chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide. It was estimated that around 3.9 million people died due to COPD. Furthermore, increase in the geriatric population and the rise in the prevalence of chronic lung diseases has increased the demand pulmonary function testing devices for disease diagnosis across the world which further boost the market growth.

Moreover, increase in R&D activity for pulmonary function testing devices, and a rise in healthcare expenditures further boost the growth of market. However, the high cost of medical devices and a lack of awareness of pulmonary tests hamper the market growth. Conversely, the emerging healthcare market in developing countries is expected to provide a lucrative opportunity for the key players operating in the market during the forecast period.

The pulmonary function testing devices market is segmented on the basis of product, test type, application, end user, and region. On the basis of product, it is segmented into portable PFT devices and complete PFT systems. On the basis of test type, the market is segmented into spirometry, peak flow meter, lung volume test, gas exchange testing, maximal voluntary ventilation, and others. On the basis of application, it is segmented into chronic obstructive pulmonary disorders, asthma, chronic shortness of breath, restrictive lung disease and others. On the basis of end user, the market is segmented into hospitals, diagnostic centers, clinical laboratories and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America dominated pulmonary function testing devices in 2021 and is anticipated to remain dominant during the forecast period due to rise in healthcare expenditure and the presence of major players in the in this region.

Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rise in prevalence of chronic diseases and increase in geriatric population.

The key players that operate in the pulmonary function testing devices market are Chest M.I Inc, Clarity Medical Pvt. Ltd., Cosmed srl, Data Sciences International Inc, Eco Medics AG, Geratherm Medical AG, JK Medical System Pvt. Ltd., Medical Electronic Construction, Medical Equipment Europe GmbH, MGC Diagnostics Corporation, Morgan Scientific Inc, NDD Medical Technologies Inc, Omron Corporation, Pulm One Advanced Medical Devices Ltd., Schiller AG, Koko LLC, and Vyaire Medical Inc

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pulmonary function testing devices market analysis from 2021 to 2031 to identify the prevailing pulmonary function testing devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the pulmonary function testing devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global pulmonary function testing devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Portable PFT Devices
- Type
- Hardware
- Software
Complete PFT Devices
- Type
- Hardware
- Software

By Test Type

Spirometry
Peak flow meter
Lung Volume Test
Gas Exchange Testing
Maximal Voluntary Ventilation
Others

By Application

Chronic Obstructive Pulmonary Disease
Asthma
Chronic Shortness of Breath
Restrictive Lung Disease
Others

By End user

Hospital
Clinical laboratories
Diagnostic Laboratories
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest Of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest Of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- SCHILLER
- COSMED srl
- NSPIRE HEALTH INC
- MGC Diagnostics Corporation
- ndd Medizintechnik AG
- Morgan Scientific Inc.,
- Ganshorn Medizin Electronic
- Minato Holdings Inc
- CHEST M.I., Inc
- Medical Equipment Europe

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Portable PFT Devices
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Portable PFT Devices Pulmonary Function Testing Devices Market by Type
  - 4.2.4.1 Hardware Market size and forecast, by region
  - 4.2.4.2 Software Market size and forecast, by region
4.3 Complete PFT Devices
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Complete PFT Devices Pulmonary Function Testing Devices Market by Type
  - 4.3.4.1 Hardware Market size and forecast, by region
  - 4.3.4.2 Software Market size and forecast, by region

CHAPTER 5: PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Spirometry
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Peak flow meter
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Lung Volume Test
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Gas Exchange Testing
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Maximal Voluntary Ventilation
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
5.7 Others
- 5.7.1 Key market trends, growth factors and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market analysis by country

CHAPTER 6: PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Chronic Obstructive Pulmonary Disease
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Asthma
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Chronic Shortness of Breath
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
6.5 Restrictive Lung Disease
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
6.6 Others
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country

CHAPTER 7: PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER

7.1 Overview
- 7.1.1 Market size and forecast
7.2 Hospital
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
7.3 Clinical laboratories
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
7.4 Diagnostic Laboratories
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
7.5 Others
- 7.5.1 Key market trends, growth factors and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market analysis by country

CHAPTER 8: PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION

8.1 Overview
- 8.1.1 Market size and forecast
8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Product
  - 8.2.2.1 North America Portable PFT Devices Pulmonary Function Testing Devices Market by Type
  - 8.2.2.2 North America Complete PFT Devices Pulmonary Function Testing Devices Market by Type
- 8.2.3 North America Market size and forecast, by Test Type
- 8.2.4 North America Market size and forecast, by Application
- 8.2.5 North America Market size and forecast, by End user
- 8.2.6 North America Market size and forecast, by country
  - 8.2.6.1 U.S.
  - 8.2.6.1.1 Market size and forecast, by Product
  - 8.2.6.1.2 Market size and forecast, by Test Type
  - 8.2.6.1.3 Market size and forecast, by Application
  - 8.2.6.1.4 Market size and forecast, by End user
  - 8.2.6.2 Canada
  - 8.2.6.2.1 Market size and forecast, by Product
  - 8.2.6.2.2 Market size and forecast, by Test Type
  - 8.2.6.2.3 Market size and forecast, by Application
  - 8.2.6.2.4 Market size and forecast, by End user
  - 8.2.6.3 Mexico
  - 8.2.6.3.1 Market size and forecast, by Product
  - 8.2.6.3.2 Market size and forecast, by Test Type
  - 8.2.6.3.3 Market size and forecast, by Application
  - 8.2.6.3.4 Market size and forecast, by End user
8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Product
  - 8.3.2.1 Europe Portable PFT Devices Pulmonary Function Testing Devices Market by Type
  - 8.3.2.2 Europe Complete PFT Devices Pulmonary Function Testing Devices Market by Type
- 8.3.3 Europe Market size and forecast, by Test Type
- 8.3.4 Europe Market size and forecast, by Application
- 8.3.5 Europe Market size and forecast, by End user
- 8.3.6 Europe Market size and forecast, by country
  - 8.3.6.1 France
  - 8.3.6.1.1 Market size and forecast, by Product
  - 8.3.6.1.2 Market size and forecast, by Test Type
  - 8.3.6.1.3 Market size and forecast, by Application
  - 8.3.6.1.4 Market size and forecast, by End user
  - 8.3.6.2 Germany
  - 8.3.6.2.1 Market size and forecast, by Product
  - 8.3.6.2.2 Market size and forecast, by Test Type
  - 8.3.6.2.3 Market size and forecast, by Application
  - 8.3.6.2.4 Market size and forecast, by End user
  - 8.3.6.3 Italy
  - 8.3.6.3.1 Market size and forecast, by Product
  - 8.3.6.3.2 Market size and forecast, by Test Type
  - 8.3.6.3.3 Market size and forecast, by Application
  - 8.3.6.3.4 Market size and forecast, by End user
  - 8.3.6.4 UK
  - 8.3.6.4.1 Market size and forecast, by Product
  - 8.3.6.4.2 Market size and forecast, by Test Type
  - 8.3.6.4.3 Market size and forecast, by Application
  - 8.3.6.4.4 Market size and forecast, by End user
  - 8.3.6.5 Spain
  - 8.3.6.5.1 Market size and forecast, by Product
  - 8.3.6.5.2 Market size and forecast, by Test Type
  - 8.3.6.5.3 Market size and forecast, by Application
  - 8.3.6.5.4 Market size and forecast, by End user
  - 8.3.6.6 Rest of Europe
  - 8.3.6.6.1 Market size and forecast, by Product
  - 8.3.6.6.2 Market size and forecast, by Test Type
  - 8.3.6.6.3 Market size and forecast, by Application
  - 8.3.6.6.4 Market size and forecast, by End user
8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Product
  - 8.4.2.1 Asia-Pacific Portable PFT Devices Pulmonary Function Testing Devices Market by Type
  - 8.4.2.2 Asia-Pacific Complete PFT Devices Pulmonary Function Testing Devices Market by Type
- 8.4.3 Asia-Pacific Market size and forecast, by Test Type
- 8.4.4 Asia-Pacific Market size and forecast, by Application
- 8.4.5 Asia-Pacific Market size and forecast, by End user
- 8.4.6 Asia-Pacific Market size and forecast, by country
  - 8.4.6.1 Japan
  - 8.4.6.1.1 Market size and forecast, by Product
  - 8.4.6.1.2 Market size and forecast, by Test Type
  - 8.4.6.1.3 Market size and forecast, by Application
  - 8.4.6.1.4 Market size and forecast, by End user
  - 8.4.6.2 China
  - 8.4.6.2.1 Market size and forecast, by Product
  - 8.4.6.2.2 Market size and forecast, by Test Type
  - 8.4.6.2.3 Market size and forecast, by Application
  - 8.4.6.2.4 Market size and forecast, by End user
  - 8.4.6.3 India
  - 8.4.6.3.1 Market size and forecast, by Product
  - 8.4.6.3.2 Market size and forecast, by Test Type
  - 8.4.6.3.3 Market size and forecast, by Application
  - 8.4.6.3.4 Market size and forecast, by End user
  - 8.4.6.4 Australia
  - 8.4.6.4.1 Market size and forecast, by Product
  - 8.4.6.4.2 Market size and forecast, by Test Type
  - 8.4.6.4.3 Market size and forecast, by Application
  - 8.4.6.4.4 Market size and forecast, by End user
  - 8.4.6.5 South Korea
  - 8.4.6.5.1 Market size and forecast, by Product
  - 8.4.6.5.2 Market size and forecast, by Test Type
  - 8.4.6.5.3 Market size and forecast, by Application
  - 8.4.6.5.4 Market size and forecast, by End user
  - 8.4.6.6 Rest of Asia-Pacific
  - 8.4.6.6.1 Market size and forecast, by Product
  - 8.4.6.6.2 Market size and forecast, by Test Type
  - 8.4.6.6.3 Market size and forecast, by Application
  - 8.4.6.6.4 Market size and forecast, by End user
8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Product
  - 8.5.2.1 LAMEA Portable PFT Devices Pulmonary Function Testing Devices Market by Type
  - 8.5.2.2 LAMEA Complete PFT Devices Pulmonary Function Testing Devices Market by Type
- 8.5.3 LAMEA Market size and forecast, by Test Type
- 8.5.4 LAMEA Market size and forecast, by Application
- 8.5.5 LAMEA Market size and forecast, by End user
- 8.5.6 LAMEA Market size and forecast, by country
  - 8.5.6.1 Brazil
  - 8.5.6.1.1 Market size and forecast, by Product
  - 8.5.6.1.2 Market size and forecast, by Test Type
  - 8.5.6.1.3 Market size and forecast, by Application
  - 8.5.6.1.4 Market size and forecast, by End user
  - 8.5.6.2 Saudi Arabia
  - 8.5.6.2.1 Market size and forecast, by Product
  - 8.5.6.2.2 Market size and forecast, by Test Type
  - 8.5.6.2.3 Market size and forecast, by Application
  - 8.5.6.2.4 Market size and forecast, by End user
  - 8.5.6.3 South Africa
  - 8.5.6.3.1 Market size and forecast, by Product
  - 8.5.6.3.2 Market size and forecast, by Test Type
  - 8.5.6.3.3 Market size and forecast, by Application
  - 8.5.6.3.4 Market size and forecast, by End user
  - 8.5.6.4 Rest of LAMEA
  - 8.5.6.4.1 Market size and forecast, by Product
  - 8.5.6.4.2 Market size and forecast, by Test Type
  - 8.5.6.4.3 Market size and forecast, by Application
  - 8.5.6.4.4 Market size and forecast, by End user

CHAPTER 9: COMPANY LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES

10.1 SCHILLER
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
10.2 COSMED srl
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
10.3 NSPIRE HEALTH INC
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
10.4 MGC Diagnostics Corporation
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
10.5 ndd Medizintechnik AG
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
10.6 Morgan Scientific Inc.,
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
10.7 Ganshorn Medizin Electronic
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
10.8 Minato Holdings Inc
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
10.9 CHEST M.I., Inc
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
10.10 Medical Equipment Europe
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments

肺機能検査装置市場：製品タイプ別、検査タイプ別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Pulmonary Function Testing Devices Market By Product, By Test Type, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章肺機能検査装置市場：製品別

第5章肺機能検査装置市場：検査タイプ別

第6章肺機能検査装置市場：用途別

第7章肺機能検査装置市場：エンドユーザー別

第8章肺機能検査装置市場：地域別

第9章企業情勢

第10章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT

CHAPTER 5: PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE

CHAPTER 6: PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION

CHAPTER 7: PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER

CHAPTER 8: PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION

CHAPTER 9: COMPANY LANDSCAPE

CHAPTER 10: COMPANY PROFILES

肺機能検査装置市場：製品タイプ別、検査タイプ別、用途別、エンドユーザー別：世界の機会分析および産業予測、2021-2031年

Pulmonary Function Testing Devices Market By Product, By Test Type, By Application, By End user : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 肺機能検査装置市場：製品別

第5章 肺機能検査装置市場：検査タイプ別

第6章 肺機能検査装置市場：用途別

第7章 肺機能検査装置市場：エンドユーザー別

第8章 肺機能検査装置市場：地域別

第9章 企業情勢

第10章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: PULMONARY FUNCTION TESTING DEVICES MARKET, BY PRODUCT

CHAPTER 5: PULMONARY FUNCTION TESTING DEVICES MARKET, BY TEST TYPE

CHAPTER 6: PULMONARY FUNCTION TESTING DEVICES MARKET, BY APPLICATION

CHAPTER 7: PULMONARY FUNCTION TESTING DEVICES MARKET, BY END USER

CHAPTER 8: PULMONARY FUNCTION TESTING DEVICES MARKET, BY REGION

CHAPTER 9: COMPANY LANDSCAPE

CHAPTER 10: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章肺機能検査装置市場：製品別

第5章肺機能検査装置市場：検査タイプ別

第6章肺機能検査装置市場：用途別

第7章肺機能検査装置市場：エンドユーザー別

第8章肺機能検査装置市場：地域別

第9章企業情勢

第10章企業プロファイル